Search
ULTIBRO BREEZHALER 110 MCG / 50 MCG, Poudre pour inhalation en gélule
Details
| --- | Description |
|---|---|
| Pack | Boite de 30 |
| Strength (Dosage) | 110 MCG | 50 MCG |
| Laboratory | NOVARTIS PHARMA MAROC |
| Ingredients | Indacaterol | Glycopyrronium |
| Therapeutic class | Anticholinergique avec bêta-2-sympathomimétique lors de BPCO |
| ATC code | R03AL04 |
| PPH | $55.80 |
| PPV | $84.30 |
| Refundable | Yes |
| Refund base | $84.30 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Ultibro Breezhaler est indiqué en traitement bronchodilatateur continu pour soulager les symptômes chez les patients adultes atteints de broncho-pneumopathie chronique obstructive (BPCO). |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem